RxDoctor Payments DataLook up a doctor →

Omar Meer, MD

Internal Medicine · East Providence, RINPI 1699824474

Payments from drug & device makers

$15,392in general payments, 2019–2025

Across 719 payments — averaging $21.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$4K
  • AstraZeneca$2K
  • Lilly USA, LLC$781
  • Johnson & Johnson$773
  • Novo Nordisk$704
  • GSK$698
  • plus $7K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Pfizer105$4,202
AstraZeneca72$1,510
Lilly USA, LLC43$781
Johnson & Johnson(2 entities)49$773
Novo Nordisk35$704
GSK39$698
Incyte Corporation33$659
Rigel Pharmaceuticals, Inc.31$621
Takeda Pharmaceuticals U.S.A., Inc.45$327
Teva Pharmaceuticals USA, Inc.19$314
Epizyme, Inc.13$291
Esperion Therapeutics, Inc.13$267
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC15$261
Amgen13$256
Merck21$252
AbbVie11$234
Mylan Specialty L.p.12$230
E.r. Squibb & Sons, L.L.C.13$220
Abbott9$194
Amarin Pharma, Inc.10$193
Boehringer Ingelheim10$191
Biohaven Pharmaceutical Holding Company Ltd.7$152
Pharmacyclics LLC, An Abbvie Company8$143
Agios Pharmaceuticals, Inc.6$126
Bayer6$119
Daiichi Sankyo Inc.6$114
Verona Pharma, Inc.4$86
Regeneron Healthcare Solutions, Inc.3$76
Currax Pharmaceuticals LLC4$73
Biohaven Pharmaceuticals, Inc.4$70
Acrotech Biopharma Inc.4$67
Gilead3$58
Shield Therapeutics Inc3$56
Sanofi3$56
Alnylam Pharmaceuticals Inc.2$55
Dexcom, Inc.2$53
Philips North America LLC3$52
Idorsia Pharmaceuticals US Inc3$50
Lundbeck LLC2$46
Tesaro, Inc.1$45
Exact Sciences2$43
Bausch Health US, LLC2$43
Exelixis Inc.2$42
Ipsen Biopharmaceuticals, Inc2$40
Astellas Pharma US Inc2$39
EMD Serono, Inc.2$39
Eisai Inc.2$39
Antares Pharma, Inc.2$38
Baxter Healthcare1$31
ADC Therapeutics America, Inc.1$28
Sumitomo Pharma America, Inc.1$28
Jazz Pharmaceuticals Inc.2$27
Geron Corporation1$27
Actelion Pharmaceuticals US, Inc.1$25
Kowa Pharmaceuticals America, Inc.1$24
Genentech USA, Inc.1$24
Mirati Therapeutics, Inc.1$23
Paratek Pharmaceuticals, Inc.1$22
Karyopharm Therapeutics Inc.1$20
Sanofi-aventis U.S. LLC1$20

How this compares

$15,392 in reported general payments places this provider in the 95th percentile of 808 internal medicine providers in Rhode Island.

See all internal medicine providers in Rhode Island →

Medicare billing

Part B allowed, 2024
$40,456
Medicare patients
78
Services billed
352

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in East Providence

See the full list for Rhode Island →

Where these figures come from

Is this you, or does something look wrong? →